Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $1.86 $3.19 Thursday, 9th May 2024 ATHE stock ended at $2.00. This is 1.96% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 8.63% from a day low at $1.90 to a day high of $2.06.
90 days $1.55 $3.19
52 weeks $1.55 $5.41

Historical Alterity Therapeutics Limited prices

Date Open High Low Close Volume
Feb 28, 2024 $1.90 $1.95 $1.82 $1.91 29 922
Feb 27, 2024 $1.85 $2.00 $1.80 $1.90 56 132
Feb 26, 2024 $1.80 $1.84 $1.70 $1.84 13 327
Feb 23, 2024 $1.80 $1.88 $1.55 $1.71 129 658
Feb 22, 2024 $2.04 $2.04 $2.04 $2.04 0
Feb 21, 2024 $1.99 $2.06 $1.96 $2.04 22 108
Feb 20, 2024 $2.00 $2.08 $1.95 $2.03 39 515
Feb 16, 2024 $1.88 $2.15 $1.88 $2.04 26 274
Feb 15, 2024 $1.89 $2.01 $1.89 $2.01 6 387
Feb 14, 2024 $1.99 $2.08 $1.85 $1.98 34 974
Feb 13, 2024 $1.96 $2.07 $1.96 $2.04 32 153
Feb 12, 2024 $1.96 $2.11 $1.92 $2.04 41 908
Feb 09, 2024 $1.98 $2.00 $1.90 $2.00 17 726
Feb 08, 2024 $1.95 $1.99 $1.89 $1.97 7 609
Feb 07, 2024 $1.93 $1.93 $1.84 $1.93 30 341
Feb 06, 2024 $2.08 $2.08 $1.88 $1.95 219 272
Feb 05, 2024 $2.02 $2.10 $2.00 $2.05 31 193
Feb 02, 2024 $2.13 $2.13 $2.00 $2.08 34 762
Feb 01, 2024 $2.24 $2.24 $2.09 $2.13 33 425
Jan 31, 2024 $2.31 $2.36 $2.02 $2.11 43 195
Jan 30, 2024 $2.12 $2.30 $2.07 $2.27 80 036
Jan 29, 2024 $1.99 $2.20 $1.96 $2.10 87 153
Jan 26, 2024 $1.95 $2.01 $1.91 $1.99 23 657
Jan 25, 2024 $1.91 $2.04 $1.85 $2.01 27 117
Jan 24, 2024 $1.84 $1.92 $1.84 $1.89 27 036
Click to get the best stock tips daily for free!

About Alterity Therapeutics Limited

Alterity Therapeutics Limited Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing PBT2 that has completed Phase IIa clinical trial to treat Alzheimer's disease. The company ... ATHE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT